VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
37 hedge funds and large institutions have $36.5M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
37
Holding in Top 10
–
Calls
$716K
Puts
$56K
Top Buyers
| 1 | +$5.4M | |
| 2 | +$1.35M | |
| 3 | +$622K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$208K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$184K |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$751K | |
| 3 | -$576K | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$459K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$288K |